Piramal Finance Limited Q1 FY2027 Results
📊
Overview
📋
Detailed Analysis
Sentiment
Positive
Executive Summary
Piramal Finance Q1 FY2027: Revenue ₹3,368.27 Cr (vs ₹2,639.25 Cr YoY), PAT ₹460.98 Cr (vs ₹276.37 Cr YoY)
Piramal Finance reported consolidated revenue from operations of ₹3,368.27 Cr in Q1 FY2027, up from ₹2,639.25 Cr in Q1 FY2026, and consolidated profit after tax of ₹460.98 Cr versus ₹276.37 Cr YoY. Total income for the quarter was ₹3,429.54 Cr and total expenses were ₹3,085.42 Cr, supporting a stronger operating result. The Board approved fundraising of up to ₹4,000 crore and continues corporate actions including Scheme-I filings with NCLT. The results reflect recovery in core lending income and one-off / non-operating volatility in fair-value lines, supporting a constructive near-term outlook...Total Revenue from operations (Consolidated) Q1 FY2027Page 17
₹3,368.27 Crvs ₹2,639.25 Cr in Q1 FY2026
Total income (Consolidated) Q1 FY2027Page 17
₹3,429.54 Crvs ₹2,690.11 Cr in Q1 FY2026
Net profit after tax (Consolidated) Q1 FY2027Page 17
₹460.98 Crvs ₹276.37 Cr in Q1 FY2026
Net profit attributable to owners (Consolidated) Q1 FY2027Page 17
₹459.12 Crvs ₹276.37 Cr in Q1 FY2026
Basic EPS (Consolidated) Q1 FY2027Page 17
₹20.38vs ₹12.22 in Q1 FY2026
Total expenses (Consolidated) Q1 FY2027Page 17
₹3,085.42 Crvs ₹2,467.44 Cr in Q1 FY2026
Finance costs (Consolidated) Q1 FY2027Page 17
₹1,733.86 Crvs ₹1,491.71 Cr in Q1 FY2026
Net profit margin (Consolidated) Q1 FY2027Page 19
13.44%Key Highlights
9
Board approved fundraising of up to ₹4,000 crore subject to approvals and market conditions
Consolidated revenue from operations increased to ₹3,368.27 Cr in Q1 FY2027 from ₹2,639.25 Cr in Q1 FY2026 driven by higher interest income
Consolidated profit before tax was ₹442.99 Cr and profit after tax was ₹460.98 Cr in Q1 FY2027, up materially YoY reflecting operating recovery and JV/associate contribution
Group received significant exceptional deferred consideration in FY2026 (USD 148.099 million / ₹1,326.36 Cr) impacting prior-year comparatives
Co‑lending portfolio (Company's share) stood at ₹2,716.36 Cr with quarterly disbursement (company share) of ₹1,452.09 Cr
Projects under implementation outstanding increased to ₹8,566.10 Cr at quarter end with 166 accounts
+3 more in Detailed Analysis →
Key Highlights
9
Board approved fundraising of up to ₹4,000 crore subject to approvals and market conditions
Consolidated revenue from operations increased to ₹3,368.27 Cr in Q1 FY2027 from ₹2,639.25 Cr in Q1 FY2026 driven by higher interest income
Consolidated profit before tax was ₹442.99 Cr and profit after tax was ₹460.98 Cr in Q1 FY2027, up materially YoY reflecting operating recovery and JV/associate contribution
Auditors' certificate concluded that minimum 100% security cover for listed NCDs was maintained as at June 30, 2026
Group received significant exceptional deferred consideration in FY2026 (USD 148.099 million / ₹1,326.36 Cr) impacting prior-year comparatives
Co‑lending portfolio (Company's share) stood at ₹2,716.36 Cr with quarterly disbursement (company share) of ₹1,452.09 Cr
Projects under implementation outstanding increased to ₹8,566.10 Cr at quarter end with 166 accounts
Net gain/(loss) on fair value changes swung to a gain of ₹12.35 Cr in Q1 FY2027 from a large gain/loss in prior quarter, indicating volatility in mark-to-market lines
Board approved Scheme‑I (amalgamation of certain subsidiaries) and filed petitions with NCLT; Scheme-I remains subject to sanction and regulatory approvals
Guidance & Outlook
4
Company authorised Committee to execute fundraising of up to ₹4,000 crore, signalling balance-sheet strengthening and liquidity plan
Management continues to pursue Scheme‑I amalgamation filings and regulatory approvals which may affect structure and capital deployment timing
Co-lending strategy will be a growth focus with Q1 co‑lending disbursement (company share) at ₹1,452.09 Cr and portfolio ₹2,716.36 Cr
Company will monitor fair-value volatility and asset quality in project finance where outstanding is ₹8,566.10 Cr at quarter end
Risks & Concerns
5
Finance costs rose to ₹1,733.86 Cr in Q1 FY2027, pressuring net interest margins and earnings if rates or funding mix deteriorate
Significant volatility in fair-value and mark-to-market lines (net fair value swing between quarters) creates earnings unpredictability
Concentration risk
Project finance pipeline includes 4 accounts under resolution with outstanding ₹256.62 Cr, indicating execution and collection risk in that portfolio
Scheme-I and other corporate reorganisations remain subject to NCLT/IRDAI and other approvals, posing execution risk and timing uncertainty
AI-generated analysis. May contain inaccuracies — verify against original sources.